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Abstract
Background: Remote telemonitoring holds great potential to augment management of patients with coronary heart disease
(CHD) and atrial fibrillation (AF) by enabling regular physiological monitoring during physical activity. Remote physiological
monitoring may improve home and community exercise-based cardiac rehabilitation (exCR) programs and could improve
assessment of the impact and management of pharmacological interventions for heart rate control in individuals with AF.
Objective: Our aim was to evaluate the measurement validity and data transmission reliability of a remote telemonitoring system
comprising a wireless multi-parameter physiological sensor, custom mobile app, and middleware platform, among individuals
in sinus rhythm and AF.
Methods: Participants in sinus rhythm and with AF undertook simulated daily activities, low, moderate, and/or high intensity
exercise. Remote monitoring system heart rate and respiratory rate were compared to reference measures (12-lead ECG and
indirect calorimeter). Wireless data transmission loss was calculated between the sensor, mobile app, and remote Internet server.
Results: Median heart rate (-0.30 to 1.10 b·min-1) and respiratory rate (-1.25 to 0.39 br·min-1) measurement biases were small,
yet statistically significant (all P≤.003) due to the large number of observations. Measurement reliability was generally excellent
(rho=.87-.97, all P<.001; intraclass correlation coefficient [ICC]=.94-.98, all P<.001; coefficient of variation [CV]=2.24-7.94%),
although respiratory rate measurement reliability was poor among AF participants (rho=.43, P<.001; ICC=.55, P<.001;
CV=16.61%). Data loss was minimal (<5%) when all system components were active; however, instability of the network hosting
the remote data capture server resulted in data loss at the remote Internet server during some trials.
Conclusions: System validity was sufficient for remote monitoring of heart and respiratory rates across a range of exercise
intensities. Remote exercise monitoring has potential to augment current exCR and heart rate control management approaches
by enabling the provision of individually tailored care to individuals outside traditional clinical environments.
(JMIR Rehabil Assist Technol 2015;2(1):e2)   doi:10.2196/rehab.3633
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Introduction
Cardiovascular diseases remain the leading cause of morbidity
and mortality worldwide, accounting for around one third
(approximately 17 million) of deaths globally, with the greatest
proportion of deaths attributed to coronary heart disease (CHD)
[1]. Cardiac rehabilitation (CR) is an essential component of
CHD management [2,3], and international guidelines
consistently identify exercise training as a central element of
CR [4-6]. The beneficial effects of exercise-based CR (exCR)
on all-cause and cardiac mortality are comparable with
comprehensive CR [7-10], and exercise training can
concurrently improve an array of modifiable cardiac risk factors
including hypertension, dyslipidemia, insulin resistance,
overweight and obesity, and exercise capacity [10-15]. Despite
these benefits, many eligible patients are not referred for CR
[16], and uptake is low among those who are referred [17,18].
Common participation barriers include transport limitations,
work commitments, and inconvenient program scheduling [19].
Among those who do undertake CR, adherence to prescribed
exercise is poor with up to 50% of participants dropping out of
regular exercise within 6 months of program completion [20-22].
It is clear traditional CR delivery models do not meet the needs
of many eligible patients, and innovation is required to enhance
participation and adherence.
Home-based exCR has been introduced to broaden access and
participation and confers similar improvements in mortality,
cardiac events, and cardiac risk factors compared to center-based
CR [23]. Home-based programs overcome several traditional
participation barriers, but many do not include physiological
monitoring that is typical during center-based exCR. In addition
to concerns about patient safety, a lack of physiological
monitoring also restricts the potential to individualize and
optimally manage exercise prescription. As the beneficial effects
of exCR are dose-dependent [11,24,25], remote physiological
monitoring may help home-based exCR participants to achieve
recommended exercise training loads and improve program
outcomes.
Physiological monitoring has recently been identified as a
particularly important direction for the future development of
home-based exCR [26], but to date, most telehealth CR
interventions have utilized fixed-line communication tools (eg,
telephone, Internet, videoconferencing, transtelephonic
electrocardiogram [ECG]) that constrain participants within the
home environment. Recent advances in mobile sensor
technologies and rapidly growing access to mobile broadband
[27] enable real-time remote physiological monitoring outside
fixed-line communication networks, and these technologies
should be integrated into telehealth CR [28].
A survey of wearable physiological monitoring devices
identified several key requirements including measurement
validity, data transmission integrity, real-time data processing,
ease of use, and scalability [29]. While few existing monitoring
systems addressed all requirements the commercially available
BioHarness (Zephyr Technology) scored highly [29]. This
multi-parameter wireless biosensor quantifies heart rate, single
lead ECG, respiratory rate, tri-axial body acceleration, and torso
posture via sensors embedded in a textile chest strap or
compression-fit vest. On-board memory and Bluetooth
connectivity enable data to be stored locally or transmitted
wirelessly to compatible devices such as smartphones, tablets,
and computers. The low-profile design, ease of use, and
advanced array of sensors make this device well suited for
remote exercise monitoring. Early model BioHarness devices
have been validated [30-35]; however, the current model has
yet to be evaluated in either clinical or non-clinical populations.
Most wearable physiological sensors do not support long-range
data transmission to remotely located monitoring stations.
Therefore, remote monitoring requires physiological sensors to
be combined with devices capable of collating and transmitting
sensor data to remote monitoring stations for review and action
by health care professionals. Smartphones are a preferable
intermediary as, in combination with appropriate mobile or Web
apps, they provide a ready-to-use mobile platform capable of
logging and transmitting data via ubiquitous wireless data
networks (eg, Bluetooth, Wi-Fi, 3G, and 4G). Portability,
compatibility with several data networks, substantial
computational capability, and routine integration of motion and
location sensors further enhance the potential utility of
smartphones for remote exercise monitoring. Moreover,
continued rapid global smartphone market penetration growth
[36] will likely reduce the necessity for health care providers
to supply smartphones to would-be remote monitoring system
end users. To date, there is a lack of published research
combining physiological sensors with mobile data transmission
technologies. A system comprising ECG and global positioning
system (GPS) sensors, and a smartphone has been evaluated
for remotely monitoring cardiac patients during exercise [37].
Remote data transmission was interrupted during 8.6% of
completed exercise sessions; however, the amount of data lost
and the subsequent impact on real-time remote monitoring were
not described.
We have developed a custom mobile app and middleware
platform to provide real-time transmission of physiological and
clinical data, via smartphones, to remotely located monitoring
centers [38]. Bi-directional communication capability enables
health care professionals to provide users with instantaneous
feedback that could prompt rapid changes in exercise behavior,
enhance exercise self-efficacy, deliver educational information
and provide support. Frequent access to remotely recorded heart
rate data during rest, activities of daily living, and exercise could
enable physicians to assess the impact of pharmacological
intervention on heart rate control. In combination with the
communication capability, this could assist physicians to titrate
AF patients’ medications in order to achieve optimal heart rate
control. Our platform has shown promise in preliminary proof
of concept research; however, a robust assessment of wireless
data transmission reliability is required.
This study aimed to evaluate the sensor measurement validity
and wireless data transmission reliability of a remote
physiological monitoring system comprising the BioHarness,
custom app, and middleware platform among individuals in
sinus rhythm. Given that AF is the most common sustained
cardiac arrhythmia and is a common comorbidity in CHD [39],
system validity was also assessed in individuals with AF to
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determine whether the sensor was robust to a common cardiac
dysrhythmia.
Methods
Overview
A dual-phase cross-sectional study was conducted to assess
system validity among convenience samples of healthy
recreationally active individuals in sinus rhythm (ie, systole
initiated at the sinoatrial node and proliferated via normal
cardiac conduction pathways; Phase One), and individuals with
AF (Phase Two). Phase One participants were recruited via
contacts and local sport clubs. Phase Two participants were
recruited via outpatient cardiology clinics. This dual-phase
approach enabled safe assessment of sensor measurement
validity across a broad range of exercise intensities. Phase One
participants completed constant, intermittent, and incremental
intensity exercise at moderate to maximal levels of intensity.
Phase Two participants completed constant intensity exercise
and simulated daily activities at low to moderate levels of
intensity. Phase One was approved by the University of
Auckland Human Participants Ethics Committee (2011/7674).
Phase Two was approved by the New Zealand Health and
Disability Ethics Committee (CEN/11/11058), respectively. All
volunteers provided written informed consent. Procedures
common to Phases One and Two are outlined below, followed
by phase-specific exercise procedures.
Common Procedures
The remote physiological monitoring system comprised the
BioHarness (version 3 with chest strap; Figure 1), a smartphone
(Xperia Arc S, Sony Ericsson Mobile Communications AB,
Sweden) utilizing the Android operating system (v2.3.4, Google
Inc.), a custom mobile app with integrated middleware platform
(Figure 2), and a remote monitoring Internet server (Odin) [38].
Physiological data, transmitted to the smartphone via Bluetooth,
were displayed throughout exercise, stored locally, and
transmitted to the remote Internet server in near real-time
(30-second data packet transmission interval).
On arrival at the laboratory, participants underwent baseline
measurement of stature and body mass, and familiarization with
exercise ergometers. Participants were instrumented with a
12-lead ECG (AT-110, Schiller AG), BioHarness, and indirect
calorimeter (Metalyzer, Cortex Biophysik GmBH). Adhesive
electrodes were applied at standard ECG sites following
recommended skin preparation procedures [40], and electrical
cables were secured to minimize signal artefact. Calorimeter
gas sensors were calibrated via a two-point procedure using
gases of known composition, the volume transducer was
calibrated using a 3000 mLcalibration syringe (Hans Rudolph),
and the internal barometer was calibrated against a mercury
barometer (SK1256, Sato Keiryoki Manufacturing).
Activation of ECG, BioHarness, and calorimeter data logging
followed a standardized procedure to ensure accurate data
synchronization. Data were recorded during 180 seconds of
seated rest prior to, and throughout exercise. A 60-second
transition period was included prior to locomotive exercise to
enable treadmill initiation.
Figure 1. Zephyr BioHarness.
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Figure 2. Custom mobile app screenshot.
Phase One Exercise Procedures
During Phase One, participants completed three discrete bouts
of treadmill running during two laboratory-based trials. During
Trial One, participants ran on a motorized treadmill (EX200,
Powersport) at 0% incline to determine the velocity eliciting
50% heart rate reserve (V50%HRR). Following instrumentation,
participants completed an incremental protocol to assess peak
oxygen uptake (V̇O2peak), operationally defined as the highest
measured V̇O2. Treadmill velocity (V50%HRR) remained constant,
and the incline was increased by 1% every 60 seconds until
volitional exhaustion. Mean V̇O2 during the final 30 seconds
of each workload was plotted as a function of treadmill incline,
and inclines eliciting 50%, 66%, 70% and 90% V̇O2peak were
derived via linear interpolation. After 30 minutes of rest,
participants completed a 30 minute constant intensity treadmill
running protocol (C30) at an incline eliciting 66% V ̇O2peak.
During Trial Two, participants completed a 30-minute
intermittent intensity treadmill protocol (I30) comprising three
repetitions of a 10-minute exercise block. Each exercise block
included five sequential 2-minute stages at inclines eliciting
50%, 70%, 90%, 70%, and 50% V̇O2peak, respectively. Mean
levels of exercise intensity were equivalent in the C30 and I30
protocols.
Phase Two Exercise Procedures
During Phase Two, participants completed three bouts of
exercise during a single laboratory-based trial. Participants
self-selected light-to-moderate levels of exercise intensity during
treadmill and cycle ergometer (Velotron, RacerMate Inc.)
familiarization. Following instrumentation, participants
undertook 10 minutes of treadmill walking, 10 minutes of
cycling, and sequential 3-minute bouts of simulated daily
activities (sweeping and vacuuming). Walk, cycle, and daily
activity bouts were separated by 5 minutes of seated rest.
Data Analysis
Reference heart rate measures were manually calculated from
synchronized ECG waveforms as the average rate during the
final 10 seconds of each minute. Reference respiratory rate was
captured by the calorimeter at 0.10 Hz. BioHarness and
calorimeter data were downloaded using the manufacturers’
software (BioHarness Log Downloader v1.0.24 and MetaSoft
v3.9.3, respectively) and exported for manual analysis.
BioHarness data were down-sampled to match reference
measures. Data outside the manufacturers specified measurement
ranges were excluded prior to analysis.
Phase One and Two data were analyzed separately following
identical procedures using SPSS v20.0.0. Consistent with
guidelines for assessing measurement validity in this field [41],
a multi-faceted approach was undertaken to evaluate BioHarness
heart rate and respiratory rate measurement accuracy and
reliability. Heart rate and respiratory rate data were
non-normally distributed, and a nonparametric analytical
approach was implemented where necessary. Wilcoxon
signed-rank tests for matched pairs were conducted to assess
systematic biases between sensor and reference measures.
Kruskal-Wallis analyses of variance were performed to assess
the effect of Activity (Phase One: rest, transition, run; Phase
Two: rest, transition, walk, cycle, sweep, vacuum) on
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measurement biases. Statistically significant main effects were
explored using Dunn-Bonferroni corrected paired comparisons.
Spearman’s rank-order correlation coefficients (rho) and
two-way random effects intraclass correlation coefficients (ICC)
for absolute agreement were calculated to describe relative
measurement reliability [41]. Absolute measurement reliability
was assessed by calculating the standard error of measurement
(SEM) and coefficient of variation (CV) [41] and a
non-parametric approach to the 95% limits of agreement (LoA)
similar to that described by Bland & Altman [42], in which the
LoA were calculated as the 2.5th and 97.5th percentile ranked
biases. The threshold for statistical significance was set at
alpha<.05.
Wireless data transmission reliability was evaluated by
determining data loss between the BioHarness, App, and remote
monitoring server (Odin). Reference sample sizes were
calculated as the product of exercise duration and sensor
sampling frequency. These analyses utilized data logged at the
BioHarness’ native summary frequency (1 Hz) as the
aforementioned down-sampling procedures had potential to
conceal intermittent data loss.
Results
Overview
Participant characteristics are summarized in Table 1. Ten and
eight participants completed all Phase One and Two activity
bouts, respectively. Unidentified trial-wide technical errors
affected heart rate and respiratory rate measurements during
two separate Phase Two trials. The outlying nature of these
datasets was confirmed by 2 independent investigators, and they
were excluded from analyses.
Table 1. Participant characteristics (Phase One: participants in sinus rhythm; Phase Two: participants with atrial fibrillation).
Phase Two, mean (SD)Phase One, mean (SD)
8/510/6Sample size/male
69.68 (9.53)26.68 (3.26)Age, years
77.46 (18.81)71.10 (11.53)Body mass, kg
1.69 (0.12)1.73 (0.06)Stature, m
Not assessed50.82 (4.51)Peak oxygen consumption, ml·kg-1·min-1
Measurement Accuracy
The BioHarness systematically underestimated heart rate
(z=-3.01, P=.003) and respiratory rate (z=-21.57, P<.001) during
Phase One, although the median biases were small (Tables 2
and 3). A statistically significant effect of Activity on
measurement bias was detected for respiratory rate (H2=40.96,
P<.001), but not heart rate (H2=0.83, P=.66). Dunn-Bonferroni
corrected paired comparisons revealed systematic differences
in respiratory rate measurement biases between all three levels
of Activity (all P<.001 to P=.04; Table 3).
The BioHarness systematically overestimated heart rate
(z=-3.28, P=.001) and respiratory rate (z=-4.47, P<.001) during
Phase Two, although negative biases were observed during
some activities (Tables 2 and 3). A statistically significant effect
of Activity was detected on respiratory rate (H5=203.07, P<.001;
Table 3), but not heart rate (H5=4.41, P=.49; Table 2).
Dunn-Bonferroni-corrected paired comparisons revealed
systematic differences in respiratory rate measurement biases
between all levels of Activity (P<.001 to P=.02; Table 3) with
the exception of walk and cycle (P=.12; Table 3).
BioHarness measurement error was relatively consistent across
the measurement ranges, although a degree of heteroscedasticity
was apparent among Phase Two respiratory rate measures
(Figure 3).
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Table 2. Biases between BioHarness and reference heart rate (Phase One: participants in sinus rhythm; Phase Two participants with atrial fibrillation)a.
Heart rate
Bias %Bias b·min-1Median b·min-1
0.02 (5.55)0.00 (4.45)72.00 (18.00)REFRestPhase One
70.75 (23.38)BH
-0.65 (7.38)-0.80 (7.20)108.00 (30.00)REFTransition
97.00 (31.18)BH
-0.20 (2.80)-0.30 (4.60)162.00 (18.00)REFRun
163.50 (16.40)BH
-0.20 (2.96)-0.30 (4.53)b
162.00 (24.00)REF
Total 160.70 (13.40)BH
2.06 (5.77)2.10 (4.55)84.00 (24.00)REFRestPhase Two
89.10 (29.45)BH
1.67 (8.78)1.10 (9.30)108.00 (6.00)REFTransition
91.70 (21.30)BH
0.49 (7.82)0.65 (9.25)126.00 (40.50)REFWalk
130.20 (46.58)BH
1.79 (9.66)1.90 (11.50)120.00 (60.00)REFCycle
121.80 (72.50)BH
-3.75 (9.70)-3.60 (12.00)108.00 (27.00)REFSweep
103.10 (20.05)BH
3.47 (13.46)3.20 (13.76)108.00 (30.00)REFVacuum
101.30 (33.34)BH
1.23 (8.61)1.10 (9.75)c
108.00 (48.00)REF
Total 106.55 (51.68)BH
aTable reports median (IQR) reference (REF) and BioHarness (BH) heart rates, absolute (b·min-1) and relative (%) biases.
bP=.003.
cP=.001.
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Table 3. Biases between BioHarness and reference respiratory rate (Phase One: participants in sinus rhythm; Phase Two participants with atrial
fibrillation)a.
Bias %Bias br·min-1 bMedian br·min-1
-1.56 (23.42)
-0.28 (4.00)tR17.00 (6.75)REFRestPhase One
16.15 (5.44)BH
-12.17 (29.52)-2.20 (5.72)rR
19.30 (7.33)REF
Transition 17.65 (6.32)BH
-3.30 (10.65)-1.36 (4.58)rt
41.70 (12.00)REF
Run 40.80 (10.09)BH
-3.33 (12.01)-1.25 (4.65)c
39.90 (15.30)REF
Total 39.02 (13.40)BH
-4.89 (21.77)
-0.88 (4.30)twcsv18.50 (6.65)REFRestPhase Two
17.29 (4.80)BH
-28.02 (23.69)-5.73 (5.97)rwcsv
19.70 (8.30)REF
Transition 14.34 (4.92)BH
3.12 (30.80)0.81 (6.34)rtsv
22.30 (5.85)REF
Walk 25.16 (6.35)BH
1.04 (28.84)0.28 (7.65)rtsv
25.00 (7.28)REF
Cycle 26.69 (6.94)BH
27.22 (77.73)6.61 (16.35)rtwcv
22.00 (6.05)REF
Sweep 31.03 (11.87)BH
43.89 (67.69)9.42 (10.18)rtwcs
19.65 (9.33)REF
Vacuum 31.55 (9.72)BH
1.56 (31.88)0.39 (7.33)c
22.10 (7.18)REF
Total 24.26 (11.02)BH
aTable reports median (IQR) reference (REF) and BioHarness (BH) respiratory rates, absolute (br·min-1) and relative (%) biases.
bThe letters r t R= rest, transition, run; statistically significantly different compared to Phase One rest, transition, Run (P<.001 to P=.04). The letters r t
w c s v
= rest, transition, walk, cycle, sweep, vacuum; statistically significantly different compared to Phase Two rest, transition, walk, cycle, sweep, and
vacuum (P<.001 to P=.02).
cStatistically significantly different compared to reference measures (P<.001).
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Figure 3. Sensor measurement error as a function of mean measurement magnitude (solid reference lines = mean biases, dashed reference lines = 95%
limits of agreement).
Measurement Reliability
BioHarness and reference heart rate measures were strongly
correlated during both phases (Table 4), indicating excellent
relative measurement reliability. The SEM, CV, and LoA for
heart rate were similar during both phases (Table 4). Small SEM
and CV indicate acceptable absolute heart rate measurement
reliability during both phases; however, the non-parametrically
derived LoA were relatively wide (Figure 3). Asymmetric LoA
reflect the aforementioned non-normal measurement error
distributions. BioHarness and reference respiratory rate measures
were strongly correlated during Phase One, but not Phase Two
(Table 4). Phase One respiratory rate SEM and CV were small,
but the LoA were relatively wide (Figure 3). The respiratory
rate SEM, CV, and LoA were substantially larger during Phase
Two (Table 4) and reflect poor absolute measurement reliability.
While the magnitude of the Phase Two respiratory rate SEM
was comparable to the heart rate SEM during both phases, it
represents a larger proportion of the total measurement range
and therefore, markedly lower absolute measurement reliability.
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Table 4. Relative and absolute reliability of BioHarness heart rate and respiratory rate measuresa.
AbsoluteRelative
CV, %LoA, min-1SEM, min-1ICCrho
2.24(-21.87, 9.26)5.20
.98b.92bHRPhase One
7.94(-13.73, 9.41)2.78.94b.87bRR
4.05(-13.39, 23.79)4.77
.98b.97bHRPhase Two
16.61(-11.58, 18.91)4.60.55b.43bRR
aTable reports Spearman’s rank-order correlation coefficient (rho), two-way random effects intraclass correlation coefficient (ICC), standard error of
measurement (SEM), non-parametric 95% limits of agreement (LoA), and coefficient of variation (CV) for heart rate (HR) and respiratory rate (RR).
bStatistically significant P<.001.
Wireless Data Transmission Reliability
Zero biases were observed between BioHarness, App, and Odin
measurements, indicating sensor measurement validity was
unaffected by wireless data transmission. Phase One BioHarness,
App, and Odin data loss were 4.1%, 0.2%, and 21.3%,
respectively. Failure to record data throughout two V̇O2peak
bouts accounted for all BioHarness data loss. However, these
errors did not compromise BioHarness-to-App data transmission.
A terminal App crash during one exercise bout accounted for
all Phase One App data loss. Outages of the data network
hosting the Odin server precluded App-to-Odin data
transmission throughout five exercise bouts, and this instability
accounted for 15.5% Odin data loss. Unidentified intermittent
data capture errors accounted for the remaining Odin data loss
(5.9%).
Phase Two BioHarness, App, and Odin data loss were 0.0%,
0.6%, and 1.1%, respectively. Phase Two was unaffected by
Odin network stability and data loss occurred as a result of
intermittent errors similar to those observed during Phase One.
Discussion
Principal Findings
This study evaluated the sensor measurement and wireless data
transmission validity of a remote physiological monitoring
system among participants in sinus rhythm and AF. Heart and
respiratory rates differed systematically from reference measures
across a range of exercise intensities and activities, but the
magnitudes of these biases were small. Measurement reliability
was generally acceptable, and wireless data capture was
excellent when all components of the monitoring system were
operational. However, instability of the data network hosting
the Odin remote monitoring server resulted in substantial data
loss during some exercise bouts.
The small magnitudes of heart rate and respiratory rate
measurement biases are unlikely to impair interpretation of
physiological stress or workload during remote monitoring. As
a caveat, larger biases during simulated sweeping and
vacuuming may indicate reduced sensor stability and increased
movement artefact during activities requiring substantial upper
limb movement. Recent evidence suggests conductive fabric
sensors embedded in a textile vest are subject to less movement
artefact than traditional adhesive ECG electrodes [43]. Thus the
BioHarness compression-fit vest may improve sensor
measurement validity; however, it was not publicly available
during this experiment and could not be assessed.
Heart rate and respiratory rate measurement biases were
comparable to some, but not all previous evaluations of similar
sensors’ measurement validity. Biases were smaller than those
reported for a previous model BioHarness during laboratory-
and field-based locomotion [31,32,34] but comparable to those
reported during incremental and constant intensity treadmill
running [35]. As it is not possible to determine the extent to
which iterative hardware and software development contributes
to measurement accuracy, caution should be taken when
generalizing our results to earlier model devices.
Relative heart rate measurement reliability was excellent across
a range of activities and workloads. Correlation coefficients
compare favorably with evaluations of previous model
BioHarness devices [32,35] and other wearable physiological
sensing devices [44-47]. Small SEM, and CV substantially
smaller than a previously established criterion for acceptability
[45] indicate good absolute heart rate measurement reliability
during both phases. Relatively wide LoA are consistent with
previous BioHarness evaluations [34,35] and reflect infrequent
large measurement errors. While high frequency data are
attractive for real-time remote exercise monitoring, the effect
of infrequent outlying measurement errors may unnecessarily
confound real-time data interpretation. Many wearable
physiological sensors support much higher frequency monitoring
than is typically provided during center-based supervised
exercise. Thus it may be acceptable to sacrifice some temporal
resolution in order to increase measurement reliability.
Post-processed down-sampling is recommended to account for
the temporal instability of respiratory gas exchange data during
exercise [48,49], and a similar approach warrants consideration
for real-time monitoring of high-frequency physiological data.
Aggregating individual data packets, which were transmitted
every 30 seconds during this experiment, may overcome the
effects of infrequent outlying measurement errors. However,
further investigation is required to determine the optimal balance
between temporal resolution and measurement reliability.
Respiratory rate measurement reliability was comparable with
evaluations of previous BioHarness models [31,35] and other
wearable physiological monitors featuring inductive
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plethysmographs during Phase One [45,47,50] but was notably
reduced during Phase Two. This was unexpected, but not
without precedent [33,34]. The major methodological
discrepancies between phases were the inclusion of upper body
activities (simulated sweeping and vacuuming), lower levels of
activity intensity, and older aged participants of lower exercise
training status during Phase Two. Activities requiring substantial
upper limb movement could impair the BioHarness respiratory
rate sensor; however, post-hoc sensitivity analyses (not
presented) did not support this effect. As low intensity activities
are associated with small tidal volumes and thoracic wall
displacements [51], it is possible the BioHarness respiratory
rate sensor may be confounded during low levels of exercise
intensity. Again, however, post-hoc sensitivity analyses did not
support this effect. Pulmonary mechanics are impaired among
older aged individuals (independent of pathophysiological
conditions) and those with respiratory muscle weakness [52,53].
However, data describing pulmonary mechanics were not
collected during this study, and the mechanism(s) underlying
poor Phase Two respiratory rate measurement reliability remain
unknown.
Remote physiological monitoring is contingent on reliable data
transmission to a remotely located monitoring station. Data
capture was generally excellent throughout this experiment;
however, several errors were identified. Unresolved data logging
errors precluded data storage on the local BioHarness memory
during two exercise bouts; however, remote data transmission
was unaffected and all data were successfully transmitted to the
remote monitoring server during these errors. While local
BioHarness data capture was necessary to assess sensor
measurement validity, the middleware platform responds to
network instability by temporarily caching all data until a
network connection is re-established. Thus local BioHarness
data capture would not be required in a production-ready remote
monitoring system. The institutional network that hosted the
Odin server throughout this study was subject to inconsistent
power supply and undisclosed maintenance events. Resulting
Odin server outages affected five exercise bouts during three
Phase One trials. Relocating Odin to a robust host network will
resolve this issue and is an immediate priority for future
iterations of the monitoring system. After accounting for host
network instability, Odin captured 94.7% and 98.9% of data
during Phases One and Two, respectively. Iterative development
is required to resolve the remaining App and Odin data capture
errors; however, data capture reliability was sufficient for
real-time remote monitoring given that a stable App-to-Odin
connection was confirmed before beginning exercise.
Limitations
A potential limitation of this study was the small sample size.
However, as the unit of analysis was the number of sensor
observations, rather than the number of participants, the design
had sufficient statistical power to detect clinically significant
biases between BioHarness and reference measures of heart rate
and respiratory rate.
As with all studies evaluating physiological sensor validity,
these results may be confounded by factors influencing the
quality of data from the BioHarness and reference sensors.
Positional overlap between ECG (V1-V6) and BioHarness
electrodes may have impaired BioHarness electrode skin contact,
particularly among participants with small chest circumferences
requiring ECG electrodes to be closely grouped. Interrupted
skin contact could explain the occasional presence of large
measurement errors apparent in the relatively wide heart rate
LoA.
Similarly, the design of the BioHarness respiratory rate sensor
dictated that it was typically located above ECG electrodes V5
and V6. Compression of the respiratory rate sensor against
underlying ECG electrodes could impair measurement validity;
however, this would be expected to affect both phases and is
unlikely to explain the reduced measurement reliability observed
during Phase Two.
Implications
Remote physiological monitoring has numerous potential
applications in both clinical and non-clinical settings. Remote
monitoring has been identified as an important future
development in home-based exCR [26] and may help to bridge
the gap between center- and home-based programs for
individuals who are unable to attend traditional exCR. Real-time
remote physiological monitoring could help home-based exCR
participants’ to achieve and adhere to recommended exercise
training loads, and this may optimize beneficial exercise-induced
physiological adaptations. Moreover, bi-directional
communication capability will enable exercise physiologists to
provide instantaneous individualized feedback, educational
information, and support based on real-time physiological
responses. While remote exCR should not replace center-based
programs, it may provide a viable alternative for those who are
unable or unwilling to attend supervised exCR. Robust trials
are now required to determine the efficacy and safety of
remotely monitored exCR. Given that center-based exCR is the
gold standard treatment in many countries, it seems prudent to
compare remotely monitored exCR with center-based programs.
Remote physiological monitoring also has potential applications
outside of exCR and could be used to monitor heart rate control
in people with AF. Management of patients with AF involves
consideration of either a rhythm control approach (attempt to
maintain sinus rhythm) or one of rate control, which is often
the preferred approach. Reduction of the rapid heart rate in AF
increases the diastolic filling periods and left ventricular stroke
volume [39]. Current guidelines recommend an individualized
approach to AF rate control, using a combination of
pharmacological agents such as beta-blockers, calcium channel
blockers, and digoxin [39]. However, heart rate control during
exercise remains problematic for many patients with AF, even
when receiving medications. Guidelines recommend that patients
who experience symptoms associated with AF during exercise
should be assessed during exercise and have their
pharmacological treatment titrated to achieve a physiological
chronotropic response and avoid bradycardia [39]. The most
common approach for monitoring arrhythmias during everyday
life is Holter monitoring (24 hours to 7 days) [39]. This approach
is highly regarded and valuable for clinical decision making;
however, it is time and resource intensive to monitor data and
can be intrusive for patients. Remote monitoring systems such
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as the one described in this paper have several advantages over
traditional Holter monitoring. The conductive textile electrodes
embedded into wearable physiological sensors overcome the
discomfort associated with adhesive electrodes. Moreover, data
from integrated motion sensors could be used to delineate
periods of rest and physical activity, and these contextual data
may augment interpretation of heart rate control among patients
with AF. Finally, embedding automated data collation and
processing within remote monitoring servers can eliminate
manual data handling and improve the efficiency of data
processing and reporting. Collectively these characteristics
could assist physicians to assess the effects of pharmacological
intervention and titrate AF patients’ medications in order to
optimize heart rate control at rest and during exercise. Future
research is needed to determine the utility of such remote
monitoring in this and other translational contexts.
Conclusion
The remote monitoring system evaluated in this experiment has
sufficient measurement accuracy for quantifying heart rate and
respiratory rate among individuals in sinus rhythm and with AF
when gold standard clinical sensors are unavailable. Wireless
data transmission reliability was generally excellent. Remote
physiological monitoring has potential application as an alternate
method for delivering exercise-based cardiac rehabilitation and
enhancing the management of heart rate control for individuals
with atrial fibrillation.
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